Cognizant Beats on Revenue but Bookings Drought Raises a Hard Question: Are Clients Rethinking How Much They Need IT Services?
Shares of Cognizant Technology Solutions cratered -10.4% to $59.48 after the company reported Q3 results that beat on the top and bottom lines but flashed a warning sign investors couldn't ignore: bookings in the third quarter declined 7% year-over-year . The selloff erased roughly $3.5 billion in market value in a single session, punishing a stock that had already slid from $73.72 just days earlier.
The Numbers Look Good Until You Read the Fine Print. Adjusted EPS of $1.49 exceeded the $1.46 consensus, while revenue of $5.66 billion was above the $5.65 billion estimate, growing 4.6% year over year. But acquisitions and resold third-party products supplied roughly 4 points of that growth , meaning organic expansion — the kind that reflects genuine new demand — was negligible. Operating margin came in at 15.4%, down 60 basis points year-over-year, indicating pressure on profitability.
Clients Are Hesitating, and That's the Real Story. Cognizant lowered its full-year constant-currency revenue growth outlook to 4% to 4.4%, citing greater-than-expected macroeconomic pressure on discretionary spending in healthcare and consumer-facing sectors, lower third-party product resale activity, and a greater impact from fourth-quarter furloughs.
Q4 revenue guidance of $5.49–$5.57 billion fell short of the $5.65 billion consensus. The bookings slump suggests corporate customers want to see that AI tools actually deliver savings before committing to large new outsourcing contracts — a wait-and-see posture that could compress revenue for quarters to come.
Rivals Are Still Winning Big Deals, Making This Look Company-Specific. Accenture and Infosys are still signing big deals, and EPAM's upcoming report will show whether the slowdown is Cognizant's alone. If peers post stronger bookings, the narrative shifts from industry-wide caution to an execution gap at Cognizant specifically — a far more damaging read for the stock.
Wall Street Was Positioned for a Breakout, Not a Breakdown. Four firms had raised their price targets in the days before the report — Wells Fargo lifted its target to $77 and Guggenheim issued an $80 objective . That bullish positioning amplified the downside when results disappointed. The analyst community remains split, with ten Buy ratings and fourteen Holds , and at $59.48 the stock now trades well below even the most cautious targets. The trailing P/E of roughly 14x sits below its five-year median of about 16x , suggesting the market is pricing in a sustained slowdown — or daring management to prove otherwise.